Team:Groningen/Template/MODULE/Project/secretion/part2

From 2014.igem.org

(Difference between revisions)
Line 17: Line 17:
<!-- PARAGRAPH SNIPPET MANDATORY START-->
<!-- PARAGRAPH SNIPPET MANDATORY START-->
<div class="text">
<div class="text">
-
Certain pathogens protect themselves by producing a extracellular polymeric substance. The bacteria encapsulate themselves with exopolysaccharides which can adhere to other cells with these extracellular “sugars”. The encapsulated pathogen can also become resistant against any type of antibiotics. If a patient becomes infected with these pathogens and the pathogens get the chance to adhere themselves to a surface, curing these infections can become very difficult.  
+
Certain pathogens protect themselves by producing a extracellular polymeric substance. The bacteria encapsulate themselves with exopolysaccharides which can adhere to other cells with these extracellular “sugars”. The encapsulated pathogen can also become resistant against any type of antibiotics. If a patient becomes infected with these pathogens and the pathogens get the chance to adhere themselves to a surface, curing these infections can become very difficult.
-
But before we try to solve this problem, how do biofilms actually form? Well, first certain individual bacteria must adhere to a surface and form micro colonies. These will be the basis of the biofilm. Then motile bacteria will try to migrate to these colonies and adhere themselves on top of the colonies. after a couple of cycles, these bacteria will have formed a mushroom kind of structure, which can release bacteria individuals. These individuals will in their turn create their own biofilm.  
+
</div>
 +
<div class="hspacer"> </div>
 +
<!-- PARAGRAPH SNIPPET MANDATORY END-->
 +
 
 +
<!-- PARAGRAPH SNIPPET MANDATORY START-->
 +
<div class="text">
 +
But before we try to solve this problem, how do biofilms actually form? Well, first certain individual bacteria must adhere to a surface and form micro colonies. These will become the basis of the biofilm. Then motile bacteria will try to migrate to these colonies and adhere themselves on top of the colonies. After a couple of cycles, these bacteria will have formed a mushroom kind of structure, which can release bacteria individuals. These individuals in their turn create their own biofilm.  
</div>
</div>
<div class="hspacer"> </div>
<div class="hspacer"> </div>
Line 27: Line 33:
<!-- PARAGRAPH SNIPPET MANDATORY START-->
<!-- PARAGRAPH SNIPPET MANDATORY START-->
<div class="text">
<div class="text">
-
So we had to think about a strategy to battle these structures. After a lot of research, Dispersin B came to our minds. The enzyme is commonly used by <i>Aggregatibacter actinomycetemcomitans</i>, which is a periodontal pathogen. Dispersin B itself catalysis the hydrolysis of N-acetyl-D-glucosamine found in the biofilm.  Therefor releasing certain bacteria, which under the right circumstances become very susceptible for antibiotics.  Therefor there has been a gigantic market opportunity for this enzyme as detergents or medicine.The enzyme is a 361 amino acids counting protein and is 40kDA big. It hydrolysis the β-1, 6-glycosidic link between the acetyl glucosamine polymers in the biofilm matrices.  
+
So we had to think about a strategy to battle these structures. After a lot of research, Dispersin B came to our minds. The enzyme is commonly used by <i>Aggregatibacter actinomycetemcomitans</i>, which is a periodontal pathogen. Dispersin B itself catalyzes the hydrolysis of N-acetyl-D-glucosamine found in the biofilm.  Thereby releasing certain bacteria, which under the right circumstances become very susceptible for antibiotics.  Therefore, there has been a gigantic market opportunity for this enzyme as detergents or medicine. The enzyme is a 361 amino acids counting protein and is 40 kDa big. It hydrolyzes the β-1,6-glycosidic link between the acetylglucosamine polymers in the biofilm matrices.  
The active site contains 3 amino acids which have highly conserved acidic residues.  
The active site contains 3 amino acids which have highly conserved acidic residues.  
-
three amino acids are D183, E184 and E322. E184 act as a Proton donator to the OR-site of the first carbon in the polymer. D183 assist the activation of the N-acetyl group, which gives of the electron to the first carbon of the polymer, then water can hydrolyse the polymer. <sup>3</sup>
+
The three amino acids are D183, E184 and E322. E184 act as a proton donator to the OR-site of the first carbon in the polymer. D183 assists the activation of the N-acetyl group, which gives of the electron to the first carbon of the polymer, so water can then hydrolyze the polymer. <sup>3</sup>
</div>
</div>
<div class="hspacer"> </div>
<div class="hspacer"> </div>
Line 38: Line 44:
<!-- PARAGRAPH SNIPPET MANDATORY START-->
<!-- PARAGRAPH SNIPPET MANDATORY START-->
<div class="text">
<div class="text">
-
The problem with <i>Pseudomonas aeruginosa</i> and <i> Staphylococcus aureus</i> is that they also can produce a biofilm which can protect them against any antimicrobial.  
+
The problem with <i>Pseudomonas aeruginosa</i> and <i> Staphylococcus aureus</i> is that they also can produce a biofilm which can protect them against any antimicrobials.  
Because of the limitations on obtaining a gene from a ML-II bacteria, we decided to
Because of the limitations on obtaining a gene from a ML-II bacteria, we decided to
-
  synthesize this gene, with the ssUSP45 and six times Histidine tag already attached.  
+
  synthesize this gene, with the ssUSP45 and 6xhistidine tag already attached.  
We decide to attach the HIS tag because of some logistic reasons concerning PCR and Gibson assembly.
We decide to attach the HIS tag because of some logistic reasons concerning PCR and Gibson assembly.

Revision as of 03:10, 18 October 2014

Dispersin B
Certain pathogens protect themselves by producing a extracellular polymeric substance. The bacteria encapsulate themselves with exopolysaccharides which can adhere to other cells with these extracellular “sugars”. The encapsulated pathogen can also become resistant against any type of antibiotics. If a patient becomes infected with these pathogens and the pathogens get the chance to adhere themselves to a surface, curing these infections can become very difficult.
But before we try to solve this problem, how do biofilms actually form? Well, first certain individual bacteria must adhere to a surface and form micro colonies. These will become the basis of the biofilm. Then motile bacteria will try to migrate to these colonies and adhere themselves on top of the colonies. After a couple of cycles, these bacteria will have formed a mushroom kind of structure, which can release bacteria individuals. These individuals in their turn create their own biofilm.
Figure 1
 
Figure 1: The creation of the biofilm
 
 
So we had to think about a strategy to battle these structures. After a lot of research, Dispersin B came to our minds. The enzyme is commonly used by Aggregatibacter actinomycetemcomitans, which is a periodontal pathogen. Dispersin B itself catalyzes the hydrolysis of N-acetyl-D-glucosamine found in the biofilm. Thereby releasing certain bacteria, which under the right circumstances become very susceptible for antibiotics. Therefore, there has been a gigantic market opportunity for this enzyme as detergents or medicine. The enzyme is a 361 amino acids counting protein and is 40 kDa big. It hydrolyzes the β-1,6-glycosidic link between the acetylglucosamine polymers in the biofilm matrices. The active site contains 3 amino acids which have highly conserved acidic residues. The three amino acids are D183, E184 and E322. E184 act as a proton donator to the OR-site of the first carbon in the polymer. D183 assists the activation of the N-acetyl group, which gives of the electron to the first carbon of the polymer, so water can then hydrolyze the polymer. 3
Figure 1
 
Figure 1: The reaction between Dispersin B and the poly saccharides.
 
 
The problem with Pseudomonas aeruginosa and Staphylococcus aureus is that they also can produce a biofilm which can protect them against any antimicrobials. Because of the limitations on obtaining a gene from a ML-II bacteria, we decided to synthesize this gene, with the ssUSP45 and 6xhistidine tag already attached. We decide to attach the HIS tag because of some logistic reasons concerning PCR and Gibson assembly.